Search for Genentech Inc and
  1. July 2, 2014

    Roche to buy US cancer drug group Seragon

    Roche has agreed to buy Seragon Pharmaceuticals, a privately owned US biotech company, for up to $1.7bn, in a deal that...

  2. February 6, 2014

    Pascal wagers AstraZeneca’s replenished pipeline will deliver

    Pascal Soriot has half-justified his £4m signing-on bonus from AstraZeneca. Shares in the drugs group have risen about 26...

Special Reports

  1. 50 Top Business Ideas

    The FT puts the spotlight on which inventions and innovations have helped to create to...
  2. Investing in South Korea 2011

    What should be done to encourage foreign financial institutions to go to South Korea?...
Search more Special Reports on this topic.

  1. September 18, 2013

    Google launches healthcare company

    Google has launched a healthcare company to attack some of the most difficult scientific problems in diseases related to...

  2. June 13, 2013

    Biotechnology

    It can trace its roots to Europe’s apothecaries in the Middle Ages and the 19th-century dye and bulk chemical producers of...

  3. April 10, 2013

    Fresh funding boosts sales at Vernalis

    Fresh funding from industry partners helped lift sales by a fifth last year to £14.6m at Vernalis, the UK-quoted biotech...

  4. March 6, 2013

    Facebook appoints second female director

    Facebook has appointed its second female director, cancer researcher Susan Desmond-Hellmann, in its latest attempt to...

  5. February 20, 2013

    Winners of life science prize revealed

    A group of Silicon Valley billionaires has clubbed together to create a 21st century rival to the Swedish Nobel Prize,...

  6. August 28, 2012

    Roche executive named AstraZeneca chief

    AstraZeneca has poached a top executive from Roche to head the Anglo-Swedish pharmaceutical company as it seeks fresh deals...

  7. July 6, 2012

    Alzheimer’s: a tale of two proteins

    The slow but inexorable spread of Alzheimer’s disease through millions of ageing brains is one of the 21st century’s great...

  8. June 21, 2012

    Roche did not report US patients’ deaths

    Roche failed to inform regulators of reports of illness and death in as many as 80,000 US patients who received the Swiss...

  9. May 15, 2012

    Battle against Alzheimer’s stepped up

    The US government has stepped up its battle against Alzheimer’s disease, launching a $100m clinical study on a drug that...

  10. April 19, 2012

    Goldman names M&A veteran to top committee

    Goldman Sachs has named Gene Sykes, a veteran mergers and acquisitions banker who specialises in media and technology deals,...

  11. March 26, 2012

    Case study: Roche’s fundraising

    The story. Roche Group, the Swiss global healthcare company, had owned a majority stake in Genentech since 1990. The...

  12. February 15, 2012

    Roche warns of fake cancer drug in US

    Distribution of fake versions of the world’s top selling cancer medicine in the US is raising concerns about the security of...

  13. January 28, 2012

    Investors brace for improved offer from Roche

    Roche this week sought to strengthen its ambitions in “targeted medicine” with a hostile $5.7bn bid for Illumina of the US,...

  14. January 27, 2012

    Roche / Illumina: take a chill pill

    Jay Flatley has run scared. The chief executive of Illumina, the US genetic diagnostic company, has implemented a “poison...

  15. January 25, 2012

    Pharma groups target specialised deals

    Roche sought to strengthen its position in personalised medicine with a $5.7bn hostile bid early on Wednesday for Illumina...

  16. December 21, 2011

    Greenhill bankers die in New Jersey air crash

    A senior Greenhill & Co investment banker, an avid pilot who worked on some of his firm’s biggest deals, was one of five...

  17. December 18, 2011

    Profile: Seo Jung-jin has sights on ‘biosimilar’ market

    Seo Jung-jin, the chief executive of Celltrion, South Korea’s leading biopharmaceutical company, has made a strong career...

  18. November 30, 2011

    Top tips for investing in Europe

    It might seem difficult to be positive on Europe with the on-going wrangling over sovereign debt in the eurozone, but...

  19. November 18, 2011

    FDA blow for blockbuster Roche drug

    The US Food and Drug Administration has revoked approval for Roche’s blockbuster drug Avastin to treat breast cancer,...

  20. November 16, 2011

    Apple: board ponders fruitful transition

    Beware of sunburn when bathing in reflected glory. There may be no more prestigious perch in global business than a seat on...

  21. FT Alphaville

    October 25, 2011

    Cohen’s SAC Capital faces insider trading probe

    SAC Capital Advisors, the hedge fund run by billionaire Steve Cohen, is facing increased scrutiny by US regulators over...

  22. September 2, 2011

    Setback for ‘off label’ use of Roche drug

    Efforts by doctors to undercut high prices on Roche’s blockbuster eye drug Lucentis have been set back by reports of...

  23. August 25, 2011

    Cook tasked with replacing Apple icon

    For many of Apple’s customers, investors and fans, the most important thing about new chief executive Tim Cook is that he is...

  24. July 21, 2011

    Avastin problems weigh on Roche

    Roche raised its earnings growth guidance to 10 per cent for the year, despite posting a 5 per cent drop in net income to...

  25. July 6, 2011

    AstraZeneca unit loses patent rights

    An English judge has dealt a blow to AstraZeneca by overruling the patent rights of MedImmune, its subsidiary, to a...

  26. July 1, 2011

    Reform FDA, says biotech group

    The biotechnology industry has proposed a fundamental overhaul of the US Food and Drug Administration to accelerate the...

  27. June 30, 2011

    Roche suffers blow on breast cancer drug

    A group advising the US Food and Drug Administration voted unanimously on Wednesday to strip Roche’s blockbuster drug...

  28. May 3, 2011

    Roche study disputes eye drug finding

    Using Roche’s cancer medicine Avastin to treat vision problems carries a greater risk of side effects than its more...

  29. April 28, 2011

    US study blow for Roche and Novartis

    Roche and Novartis suffered a setback to the prospects for their blockbuster eye treatment Lucentis after the preliminary...

  30. February 22, 2011

    Ten Questions - Laura Mace

    Laura Mace: “Knowing my limits is important” Laura Mace is an MBA student at Manchester Business School in the UK. Born in...

  31. FT Alphaville

    February 16, 2011

    Sanofi agrees $20.1bn Genzyme takeover

    Sanofi-Aventis brought an end to its protracted pursuit of Genzyme with an agreed $20.1bn cash takeover of the US biotech...

  32. February 16, 2011

    Conditional payment cure for pharma deals

    The head of Sanofi-Aventis predicted more use of conditional payments in future biotechnology takeovers, as he clinched the...

  33. January 18, 2011

    Roche finance chief to exit after 10 years

    Roche, the Swiss pharmaceutical group, on Monday said it would replace Erich Hunziker, its long-standing chief financial...

  34. December 16, 2010

    Roche in challenge to FDA’s ruling

    Roche has launched an unusual challenge to the US drugs regulator after a demand that it withdraw its blockbuster drug...

  35. November 17, 2010

    European pharmaceuticals

    The European pharmaceuticals sector is in a whirl this week. It is symptomatic of an industry ever more alarmed by the...

  36. November 17, 2010

    Roche to slash staff numbers by 6%

    Roche will cut 4,800 jobs – or 6 per cent of its workforce – to save SFr2.4bn ($2.4bn) a year, as the Swiss pharmaceuticals...

  37. September 25, 2010

    Tech firms agree to halt anti-poaching deals

    Two of the world’s leading technology companies – Google and Apple – agreed to halt employment practices that restricted...

  38. July 22, 2010

    Roche plays down US bar on cancer drug

    Roche tried to limit the impact of a US regulatory panel’s recommendation to restrict one of its key cancer drugs, as it...

Search for Genentech Inc and